Wir haben festgestellt, dass Sie unsere Website von Vereinigte Staaten aus besuchen.
Für Ihr Land (Vereinigte Staaten) gibt es eine eigene Version der Website.

Zu Vereinigte Staaten wechseln
 Experts on Air

Experts On Air - INTELLiVENT‑ASV webinar series

Banner for Experts on air - INTELLiVENT-ASV Banner for Experts on air - INTELLiVENT-ASV

What is Experts On Air? And how can I participate?

Take a front‑row seat to hear live interviews with clinical experts! You can expand or refresh your knowledge on various aspects of respiratory support and get valuable tips for your daily practice.

  • A series of live Zoom events on different aspects of a central topic

  • Events are between 30 and 60 minutes in duration

  • Each event features a presentation by the speaker together with questions from the interviewer

  • Anyone can join but registration is necessary

  • Sign up below to receive your access link and a link to the recording after the event

  • You can ask the experts any questions directly during the webinar

Webinar series on INTELLiVENT‑ASV: Up close and personal

We are sure you have heard the story of automation in mechanical ventilation. But there are so many more stories than just that one! Join our experts as they tell you their stories about the many faces of INTELLiVENT‑ASV: As the protector of both the lungs and the brain, as the chameleon who adapts to every patient condition, as your assistant at every bedside, even up in the air. We look to forward to seeing you on air with our experts.

The experts

The stories

Take a front-row seat. Sign up now!

Webinar 1. INTELLiVENT-ASV: Everything you need to close the loop

Below you can find the answers to those questions not addressed during the webinar and follow the link to access the webinar's recording.

This depends on the patient's disease and lung condition, but for example in ARDS patients it is common to target a somewhat lower SpO2 of 90-94% to prevent excessive oxygen use and thus help prevent VILI. This usually results in a lower level of oxygen.

We used and still use APV-CMV (adaptive pressure ventilation), pressure controlled ventilation, pressure support ventilation and ASV.

When there is a measurement failure for any reason, INTELLiVENT-ASV will stop adjusting and freeze settings, and will generate alarms. If there is no solution at that time, i.e., SpO2 measurement due to poor perfusion, you can choose to set the controller to 'manual'.

The set I:E ratio by INTELLiVENT‑ASV is based on the RCexp, also known as the time constant. Meaning that there is a measurement of the duration of expiration based on lung mechanics and the expiration time will adjust to that. For example, for a lung with high compliance like COPD, INTELLiVENT‑ASV will set a longer expiration time and therefore prevent for auto‑PEEP.

Indeed, you try to ensure the best measurement with different options, and if the quality of the measurement is poor due to the illness of the patient, you can choose to set the controller to 'manual' until measurements are improved, then you can turn back to 'automatic'.

This is a matter of setting PEEP limits well or if necessary you can always set PEEP to 'manual'. Then you still have the advantage of automated adjustments of FiO2 and automated setting and adjustments of the VT/RR combination.

We have used it in these patients, but comparable to conventional ventilation you still need to check tidal volumes, pressures and adjust where necessary.

I think this is comparable to conventional ventilation, where you also check the pCO2 in the arterial blood gas and adjust settings where necessary.

In my experience, there are no unwanted pressure drops in spontaneously breathing patients.

Regarding implementation, this could be a webinar of its own :). Our team is focused on innovation and there are good arguments for using INTELLiVENT-ASV.

Well, as explained in the webinar, as a user you are still in control and are supervising the ventilator and adjusting targets, limits and settings, if necessary with measurements like Vd/Vt and pH.

There is, in my opinion, not a specific difference between these patient groups, good results achieved in both groups.

No, this is the responsibility of the caregiver, because you are still in control of settings, limits and additional measurements for setting ventilation parameters. 

The logic behind selecting a specific breathing pattern (Vt and RR) is based on lung mechanics, and it’s clearly described in literature. The algorithms used by INTELLiVENT-ASV for CO2 elimination and oxygenation are based on patient signals and user-set targets and limits. The way INTELLiVENT-ASV sets the parameters based on lung mechanics and "how and why" is available in the ventilator's operator’s manual, as well as in the clinical literature.

Webinar 2. INTELLiVENT-ASV: For individualized lung-protective ventilation

Below you can find the link to the recording, as well as answers to those questions not addressed during the webinar.

ARDS due to COVID is not that different in terms of PEEP compared to other causes of ARDS. Some patients have good potential for recruitment and should be ventilated with PEEP above 10 cmH2O, while others have very low potential and should be ventilated with low PEEP. A P/V curve may help to assess recruitability using the same threshold as for ARDS.

This is not easy. For the moment, the ventilator does not provide this variable. So we have to calculate it manually using one of the simplified formula published. 

There are published data showing that the number of manual settings is decreased by half when using INTELLiVENT-ASV, as compared to conventionnal modes. How this translates in terms of workload, namely the time spent by caregivers to perform these tasks and the cognitive involvment, is unknown. Clinicians that use INTELLiVENT-ASV on a regular basis claim that it decreases workload, but we have no data to support it.

INTELLiVENT-ASV should not be used in the case of bronchopleural fistula or in the case of dyshemoglobin. I consider that we have to be careful in severe COPD or asthmatic patients, and severe ARDS, because we may have to use different targets and accept higher airway pressure.

INTELLiVENT-ASV keeps end-tidal CO2 within the targets set by the user, with a permissive hypercapnia concept. Clinician should check ABGs regularly, in particular for pH and the potential gradient between PaCO2 and end-tidal CO2. In case of permissive hypercapnia with PaCO2 higher than 55 mmHg, clinicians should check if there is no pulmonary hypertension using cardiac echo.

Yes, the same way as in other cases.

Yes, the same way as in other cases.

If expiration is passive, Rcexp is accurate. If the patient has an active expiration or cough, it is not accurate.

Webinar 3. Closed-loop ventilation: If you think no improvement is needed

Below you can find the link to the recording, as well as answers to those questions not addressed during the webinar. These questions have been commented on by both the speaker and the interviewer.

Speaker's response: The question is what you call 'protective' - usually it refers to tidal volume size and as explained in some patients, those with a relative normal compliance, ASV and INTELLiVENT-ASV 'use' or 'allow' larger tidal volumes; if you refer to protective ventilation as ventilation with a low driving pressure or low mechanical power, realize that ventilation per se is not a treatment: If lung conditions are such that driving pressure or mechanical power cannot be reduced, one should consider another lung-protective strategy, ECMO.

Interviewer's comments: The question is referring to manual controls. Actually, one of the purposes of advanced automation is avoiding possible human mistakes on manual controls. However, even INTELLiVENT-ASV includes some manual controls for fine-tuning, and Hamilton Medical ventilators provide all conventional modes with manual controls. All of them must have large ranges conceived to face uncommon needs or conditions, but this means (as you say) exposure to the risk of an inappropriate setting. The risk is considered to be largely mitigated by these controls being operated only by trained personnel, i.e. by the strength of education. Nevertheless, adding some GUI tool to force the user's attention to uncommon (possibly inappropriate) settings may be an idea to be considered.

Speaker's response: Correct, herein it follows the principles of Otis, and thus bases expiration (and thus inspiration) time on the expiratory time constant (RCexp): If high, a longer expiration time is needed, and thus the inspiration time will be shorter, and vice versa.

Interviewer's comments: This is an important observation. ASV pays much attention to an individualized setting of Ti, based on the best balance between the assigned expiratory time (Te) and the speed of exhalation as reflected by the expiratory time constant (RCexp). This typically results in an I:E of 1:1 in lung restriction, 2:3 or 1:2 in mechanically normal lungs, and lower than 1:2 in lung obstruction. This approach works effectively against air trapping and avoids unnecessary high inspiratory flow rates. Also, it mimics the natural human respiratory center response to deviation from normal respiratory mechanics.

Correct, when the compliance is relatively normal, it could be better to use a somewhat higher tidal volume in case the use of a lower tidal volume mandates a higher respiratory rate: The respiratory rate adds to the power of ventilation, so should better stay low.

Speaker's answer: Due to the leakages it is not safe to use.

Interviewer's comment: Only good tightness would allow appropriate responses and good performance. Since we well know that good tightness is not continuously guaranteed during NIV, the answer is: "It is recommended NOT to use I-ASV with a mask as an interface".

Speaker's answer: Appreciation comes with experience, knowledge and understanding: Training, understanding what happens in the machine (it should not be a black box) and working with the mode - first with a small group of users and later on the whole team - may all help.


The contents of this page are for informational purposes only and are not intended to be a substitute for professional training or for standard treatment guidelines in your facility. The responses to the questions on this page were prepared by the respective webinar's speaker;  any recommendations made here with respect to clinical practice or the use of specific products, technology, or therapies represent the personal opinion of the speaker only, and may not be considered as official recommendations made by Hamilton Medical AG. Hamilton Medical AG provides no warranty with respect to the information contained ion this page and reliance on any part of this information is solely at your own risk.